KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Common Equity (2016 - 2025)

Evolent Health has reported Common Equity over the past 12 years, most recently at $415.2 million for Q4 2025.

  • Quarterly results put Common Equity at $415.2 million for Q4 2025, down 58.53% from a year ago — trailing twelve months through Dec 2025 was $415.2 million (down 58.53% YoY), and the annual figure for FY2025 was $415.2 million, down 58.53%.
  • Common Equity for Q4 2025 was $415.2 million at Evolent Health, down from $842.2 million in the prior quarter.
  • Over the last five years, Common Equity for EVH hit a ceiling of $1.1 billion in Q1 2023 and a floor of $415.2 million in Q4 2025.
  • Median Common Equity over the past 5 years was $877.7 million (2022), compared with a mean of $854.1 million.
  • Biggest five-year swings in Common Equity: skyrocketed 3383.78% in 2021 and later tumbled 58.53% in 2025.
  • Evolent Health's Common Equity stood at $693.6 million in 2021, then rose by 23.9% to $859.4 million in 2022, then rose by 24.24% to $1.1 billion in 2023, then dropped by 6.22% to $1.0 billion in 2024, then tumbled by 58.53% to $415.2 million in 2025.
  • The last three reported values for Common Equity were $415.2 million (Q4 2025), $842.2 million (Q3 2025), and $896.0 million (Q2 2025) per Business Quant data.